CUS | USES | p-value | |
---|---|---|---|
Sample size | 47 | 40 | – |
Age (years) | 59.30 ± 11.18 | 58.30 ± 9.15 | 0.654 |
Gender, N (%) | 1.000 | ||
Male | 33 (71.70%) | 28 (70.00%) | |
Female | 13 (28.30%) | 12 (30.00%) | |
Height (cm) | 166.89 ± 7.02 | 169.75 ± 6.20 | 0.059 |
Weight (kg) | 65.00 ± 9.54 | 67.36 ± 9.01 | 0.260 |
BMI (kg/m2) | 23.29 ± 2.74 | 23.39 ± 3.02 | 0.873 |
Smoking, N (%) | 18 (39.10%) | 15 (38.50%) | 1.000 |
Medical condition, N (%) | |||
Hypertension | 15 (31.90%) | 7 (17.90%) | 0.219 |
Diabetes | 6 (13.00%) | 3 (7.70%) | 0.656 |
Heart diseases | 3 (6.50%) | 5 (13.20%) | 0.511 |
Arrhythmia | 3 (6.80%) | 1 (2.60%) | 0.697 |
Cancer stage, N (%) | 0.528 | ||
Stage I | 16 (42.10%) | 18 (51.40%) | |
Stage II | 8 (21.10%) | 3 (8.60%) | |
Stage III | 11 (28.90%) | 11 (31.40%) | |
Stage IV | 3 (7.90%) | 3 (8.60%) |